|
| Home : Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics. |
|
May 02
2013 |
Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics. |
|
RICHMOND, Calif., May 2, 2013 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in new proprietary bi-functional metal-chelation technology for use in targeted radiopharmaceuticals has announced that Algeta ASA (OSE:ALGETA), a company focused on the development of novel... |
|
|
|
| Source:http://www.prnewswire.com/news-releases/algeta-and-lumiphore-announce-further-expansion-of-their-global-partnership-for-the-development-of-targeted-alpha-pharmaceutical-cancer-therapeutics-and-companion-diagnostics-205725381.html |
| |
|
Related News
|
» Zebra Technologies Announces Financial Results for the 2013 First Quarter
» Big Brother is, Quite Literally, in your Phone...
|
|
|
